Methylcholanthrene

interleukin 2 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 9174229 Effect of lipid emulsion on IL-2 production by mononuclear cells of newborn infants and adults. 1997 Apr 1
2 1883912 The effects of interleukin-2 on bone marrow engraftment in a murine model. 1991 Jun 2
3 2783379 Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice. 1989 Jan 15 1
4 2789150 Chemoimmunotherapy of MC-induced mouse sarcomas with human recombinant interleukin 2 and cyclophosphamide: age-dependent decline of the therapeutic efficacy. 1989 1
5 3143703 Effects of a combination of cyclophosphamide and human recombinant interleukin 2 on pulmonary metastasis after the surgical removal of a 3-methylcholanthrene-induced primary tumor in autochthonous mice. 1988 Oct 1
6 3257158 Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide. 1988 Jan 1 2
7 3258905 Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor. 1988 Apr 1
8 3259499 [Characteristics of production and sorption of interleukin 2 by lymphoid cells during growth of transplanted sarcoma]. 1988 2
9 2960636 Effect of methylcholanthrene on human natural killer cell cytotoxicity and lymphokine production in vitro. 1987 Sep 2
10 3496953 Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. 1987 Aug 1 1
11 3488924 Local treatment with human recombinant interleukin 2 inhibits growth of MC-induced sarcomas in syngeneic mice. 1986 1
12 3492396 Immunotherapy of murine sarcomas with interleukin 2. I. Local administration of human recombinant IL-2 preparations. 1986 1